Micron's $100 Billion Backlog: Are Take-or-Pay Agreements Changing the Memory Cycle?

Micron's $100 Billion Backlog: Are Take-or-Pay Agreements Changing the Memory Cycle?

The memory chip industry has historically been plagued by vicious boom-and-bust cycles, but Micron is taking aggressive steps to rewrite the rules. In this episode of Chip Stock Investor, we discuss Strategic Customer Agreements (SCAs).

We break down the "take-or-pay" contracts, explaining how they protect Micron from the sudden order cancellations and double-booking panics that burned the industry in 2022 and 2023. With competitors like Samsung and SK hynix also completely sold out of capacity, Micron is actively leveraging its position to lock in upfront cash deposits and secure its long-term financial runway.

  • The Take-or-Pay Mechanism: How Micron's new agreements force customers to either take delivery of the product or pay a pre-agreed minimum cancellation charge to protect Micron's bottom line.

  • A $100 Billion Backlog: Exploring the massive pipeline generated by these SCAs, which are expected to make up about 40% of Micron's total revenue over the next five years.

  • Locked-In Terms: A detailed look at the five-year contracts for hyperscalers (running from calendar 2026 through 2030) and three-year contract terms for automotive customers.

  • Pricing Safeguards: How these contracts are structured using floor prices, ceiling prices for existing products, and fixed rates to stabilize revenue against market volatility.

  • $22 Billion in Upfront Cash: Why tech giants and hyperscalers are depositing billions directly onto Micron's balance sheet to guarantee their spot in line for memory chips.

  • The Albemarle Blueprint: What Albemarle's long-term lithium contracts can teach us about how Micron's SCAs might help them weather future oversupply environments and market downcycles.

Resources Mentioned:For a growing library of tools for your analysis of semiconductor companies, visit chipstockinvestor.com. Don't forget to hit follow on Spotify so you never miss an episode!

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(492)

Twist Bioscience Soared — We're Still Not Buying

Twist Bioscience Soared — We're Still Not Buying

Twist Bioscience (TWST) just had a massive run-up after Anthropic's protein design results put its DNA synthesis platform in the spotlight. Here's what's really driving the stock — and whether it's st...

17 Syys 14min

The Fastest-Growing Chip Stock Is Also the Most Hated

The Fastest-Growing Chip Stock Is Also the Most Hated

We compare Credo (CRDO) against Broadcom (AVGO), Marvell (MRVL), and Astera Labs (ALAB) on revenue growth, gross margin, operating margin, and free cash flow margin — four fabless companies selling in...

15 Syys 13min

AI Data Center Spending Means Good Times For Semiconductors Continue -- Oracle ORCL Stock Analysis

AI Data Center Spending Means Good Times For Semiconductors Continue -- Oracle ORCL Stock Analysis

We break down the takeaways from Oracle's (ORCL) Q1 fiscal 2027 earnings call — what to expect through 2026 and into 2027–2028 as hyperscaler CapEx stays high but is set to slow in growth by 2027, and...

14 Syys 12min

Nvidia's Biggest Acquisition Ever: $12.9B for Hugging Face (Can It Survive Regulators?)

Nvidia's Biggest Acquisition Ever: $12.9B for Hugging Face (Can It Survive Regulators?)

Nvidia just proposed its largest acquisition ever — $12.9 billion for Hugging Face. But regulators in the US, EU, and China may have other plans.Nvidia has announced plans to acquire Hugging Face, the...

10 Syys 15min

Pure Storage Is Now Everpure — and Free Cash Flow Just Went Negative (P Stock)

Pure Storage Is Now Everpure — and Free Cash Flow Just Went Negative (P Stock)

Pure Storage just rebranded to Everpure — and in the same stretch, free cash flow went negative 20% in a single quarter. Here's what's really going on.Pure Storage has officially rebranded as Everpure...

10 Syys 19min

Procept Is Down 80% and the Tech Works — So Why Won't We Buy PRCT?

Procept Is Down 80% and the Tech Works — So Why Won't We Buy PRCT?

Procept BioRobotics is down roughly 80% from its 2025 highs but the technology behind its Aquablation system genuinely works. So why won't we put PRCT in our portfolio?Procept (PRCT) has one of the mo...

10 Syys 28min

Why Oscar Health's 'Great Quarter' Isn't What It Looks Like

Why Oscar Health's 'Great Quarter' Isn't What It Looks Like

Oscar Health looks like a screaming buy — growing revenue, growing members, positive free cash flow. So why does the market keep discounting it? We ran the numbers.Oscar Health (OSCR) just posted stro...

10 Syys 11min

Palo Alto Is Up 1,400% in a Decade — What Comes Next? (PANW FY2026)

Palo Alto Is Up 1,400% in a Decade — What Comes Next? (PANW FY2026)

Palo Alto Networks (PANW) has been flying high into the end of FY2026. After a decade-long 1,400% run — capped by a broader cybersecurity rally following the Anthropic "Mythos moment" in early 2026 — ...

2 Syys 14min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
vallattomat
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-oivalluksia-rahasta-elamasta
ostan-asuntoja-podcast
oppimisen-psykologia
lakicast
rss-paasipodi
rss-alanvaihtajat
rss-porssipodi
rss-karon-grilli
rss-startup-ministerio
rss-inderes
rss-siksi-viestinta
rahapuhetta
hyva-paha-johtaminen
rss-pinnan-alle
rss-sami-miettinen-neuvottelija